Devon PCT will routinely publish anonymised responses to FOI requests, where these are of a general nature and are considered to be of public interest.

Please be aware that although the information on this page was accurate at the time of publishing, it may now not be and should not be relied on.        

• FOIDV1303 – Dementia care – response and attachment A1
• FOIDV1304 – NICE guidance back pain – response
• FOIDV1305 – Locally enhanced services – response and attachments A1, A2, A3, A4, A5, A6, A7, A8, A9, A10, A11, A12, A13, A14, A15, A16
• FOIDV1306 – Doctors poor performance – response
• FOIDV1307 – Product samples for maternity hospitals – response
• FOIDV1308 – Bariatric surgery – response and attachment A1
• FOIDV1309 – Acupuncture – response
• FOIDV1310 – Zero tolerance – response and attachment A1
• FOIDV1311 – Audit data capture software – response 
• FOIDV1312 – Equipment for obese patients – response
• FOIDV1313 – Audiology social enterprise contract – response
• FOIDV1314 – Medical insurance and occupational health – response
• FOIDV1315 – Varicose vein treatment – response
• FOIDV1316 – ICT request – response
• FOIDV1317 – Eastern Devon consortia pathfinder – response
• FOIDV1318 – Prescribing formulary – response
• FOIDV1320 – GP commissioning consortia – response and attachment A1
• FOIDV1321 – CAMHS – response
• FOIDV1322 – Male circumcisions – response
• FOIDV1323 – Elective surgery – response
• FOIDV1324 – Referral for elective surgery – response
• FOIDV1325 – Paediatric continence services – response
• FOIDV1326 – IM&T department – response and attachment A1
• FOIDV1327 – Endovascular aneurysm repair – response
• FOIDV1328 – External consultants – response
• FOIDV1329 – Practice manager details – response and attachment A1
• FOIDV1330 – Consortia board members – response and attachment A1
• FOIDV1331 – Mutliple births – response
• FOIDV1332 – GP information – response
• FOIDV1333 – Girls with Aspergers – response
• FOIDV1334 – GP contracts – response
• FOIDV1335 – Tendering – response
• FOIDV1336 – Drug budget savings – response
• FOIDV1337 – Emergency activity at hospitals – response
• FOIDV1338 – Referrals reduction – response
• FOIDV1340 – Restrict GP referrals – response and attachments A1, A2, A3, A4, A5, A6, A7
• FOIDV1341 – QIPP and long term conditions – response
• FOIDV1342 – Fertility treatment – response
• FOIDV1343 – Inflammatory bowel disease – response and attachment A1
• FOIDV1344 – GP consortia – response
• FOIDV1345 - Consortia information – response and attachments A1, A2, A3
• FOIDV1346 – Royal Wedding Overtime – response
• FOIDV1347 – Eating Disorders – response
• FOIDV1348 – IVF Treatment – response
• FOIDV1350 – Contact Details – response and attachment A1
• FOIDV1351 – LINk Meetings – response and attachments A1, A2
• FOIDV1352 – Smoking Cessation – response
• FOIDV1353 – Hospital Mistakes – response
• FOIDV1354 – Overtime Payments – response
• FOIDV1355 – Continuing Health Care – response
• FOIDV1356 – Individual Funding Requests – response
• FOIDV1358 – Payments to Electoral Reform Society – response
• FOIDV1359 – Newsletters and Magazines Published – response
• FOIDV1360 – One Year Olds Health Review – response
• FOIDV1361 – Under 18 Alcoholics – response
• FOIDV1362 – Joint Working with Pharmaceutical Industry – response
• FOIDV1364 – PFI – response
• FOIDV1365 – Funding for Voluntary Sector Groups – response
• FOIDV1366 – Formulary – response
• FOIDV1367 – Parkinsons Disease Neurology – response
• FOIDV1368 – Dentists in Newton Abbot – response
• FOIDV1369 – Joint Commissioning of Services – response
• FOIDV1370 – Lease Cars – response
• FOIDV1371 – Out of Hours Service – response
• FOIDV1372 – Services for People with Breast Cancer – response
• FOIDV1373 – Document Management – response
• FOIDV1374 – Improving Access to Psychological Therapies – response
• FOIDV1375 – GP Email Addresses – response and attachment A1
• FOIDV1376 – Acute Spending – response
• FOIDV1377 – Practice Numbers – response
• FOIDV1378 – Obstructive Sleep Apnoea Syndrome – response
• FOIDV1379 – Cancer Drugs Fund – response